Gas chromatograph/mass spectrometer/computer systems can be used to quantify a wide variety of compounds of clinical interest. A quadrupole instrument operated in the chemical ionization (Cl) mode was used in these studies. Because of the sensitivity and specificity of selective ion detection, it is possible to make measurements routinely in the nanogram to picogram range, with 0.1-1.0 ml samples of plasma and 1-5 ml samples of urine. Internal standards, preferably stable-isotopelabeled compounds, were added to the biological samples before isolation was begun. We describe clinical applications of these procedures to problems in toxicology, pharmacokinetics, and perinatal pharmacology.
Gas chromatograph/mass spectrometer/computer systems can be used to quantify a wide variety of compounds of clinical interest. A quadrupole instrument operated in the chemical ionization (Cl) mode was used in these studies. Because of the sensitivity and specificity of selective ion detection, it is possible to make measurements routinely in the nanogram to picogram range, with 0.1-1.0 ml samples of plasma and 1-5 ml samples of urine. Internal standards, preferably stable-isotopelabeled compounds, were added to the biological samples before isolation was begun. We describe clinical applications of these procedures to problems in toxicology, pharmacokinetics, and perinatal pharmacology. 
Procedures
The nonacidic drugs and drug metabolites were isolated from plasma, urine, breast milk, and amniotic fluid by using ammonium carbonate/ethyl acetate as a salt/solvent pair (11). The internal standard, usually the drug labeled with a stable isotope, was added to the sample before extraction.
For analysis by GC-MS it was necessary to convert most of the drugs and drug metabolites to derivatives. Methylated, ethylated and silylated derivatives were prepared as described (1) . The isolation procedure takes 20 mm; derivatization may require 30-60 mm, and the instrumental analysis time is 10-15 mm.
Results and DiscussIon
For quantitative analysis by GC-MS-COM systems, suitable internal standards are required. Stable-isotope-labeled internal standards are preferred, and several carbon-13 and deuterium labeled compounds are available. When labeled standards were not available, analogs or homologs were used. For example, 2,2,3-trimethylsuccinimide was used as an internal standard for 2-ethyl-2-methylsuccinimide (ethosuximide), and N-methyl-2-phenylsuccinimide was used as the internal standard for N, 2-dimethyl-2-phenylsuccinimide (methsuximide) (1) .
An N-C2H3-labeled drug can be used as the internal standard for drugs and their demethylated metabolites, if ethylated rather than methylated derivatives are prepared (1) . In our studies, N-C2H3-caffeine was used as the internal standard for caffeine and for the demethylated metabolites, 1,3-, 3,7-, and 1,7-dimethylxanthines.
An analysis of human amniotic fluid is shown in Figure 1 in which N-C2H3-caffeine was used to quantify caffeine and the ethylated derivative of the metabolite theobromine (1-ethyl-3,7-dimethylxanthine).
When compounds other than stable-isotope-labeled analogs are used as internal standards, it is necessary to determine a response factor. The response factor is defined as the ratio of the peak area per microgram of drug divided by the peak area per microgram of internal standard, and must be determined for each analytical system used. The response factors were constant over the range of concentrations measured. The response factor determined with the Finnigan 1015-PDP 8/I system for 2-ethyl-2-methylsuccinimide (ethosuximide), with 2,2,3-tnmethylsuccinimide as the internal standard, was 1; the response factor for ethylated theobromine, with N-C2H3-caffeine as the standard, was 0.
was used as the standard for ethylated mephobarbital (N-ethyl-N-methylphenobarbital) the response factor was 1.55.
Quantification of hydroxylated metabolites is a more troublesome problem, because many of these metabolites are not available as pure reference standards and they are frequently difficult to synthesize. Thus it would not be possible to obtain a calibration curve or a response factor. Under these circumstances, a hydrocarbon or drug with suitable gas-chromatographic properties can be added as an internal standard. Quantification is then based on an area relationship, assuming a response factor of 1. The area relationship of the metabolite to the internal standard should be linear over the range of concentrations measured. In Figure 2 , three monohydroxyl me- These results represent only the ratio of the areas of metabolites to the standard. However, the area relationship can be converted to mg/liter subsequently by multiplying by a constant (k), the response factor, which can be determined whenever the metabolites become available as pure compounds.
Because many biological samples are unique and can never be replaced, it is better to measure them in this fashion than to discard the sample.
At present, these analytical techniques are probably more useful in clinical research than in routine clinical analysis. The methods are particularly valuable in the area of perinatal pharmacology because of the small size of the biological samples that are available for analysis. In our study of the total exposure of the fetus/neonate to pharmacologically active agents, we found that most drugs ingested by the gravid female were transferred across the placenta to the fetus (13). As a result, the urinary drug profiles of the mother and her newborn infant were qualitatively similar; however, there were quantitative differences, as illustrated in Figures 3 and 4 were present in the maternal urine, while phenylethylmalondiamide was the major metabolite in the infant's urine. e Drug present but not quantified. Samples of the cord blood, breast milk, and maternal and neonatal plasma were also obtained from this mother/infant pair. Phenobarbital was measured in all of the samples; the results are listed in Table 2 . From the analysis of maternal plasma collected 31 days before delivery and of cord blood, it is clear that the fetus was exposed to the drug and some of the metabolites in utero. Because drugs are transferred from the mother's circulation to the fetus, they should be excreted into amniotic fluid by the fetus. In a related study, samples of amniotic fluid, collected before delivery and before administration of drugs during labor, were analyzed for the presence of drugs and their metabolites. Caffeine and theobromine were identified in all of the samples (see Figure 1) . Paired samples of blood and amniotic fluid were obtained from several patients, and concentrations of caffeine and theobromme in amniotic fluid and the mother's plasma were compared. It was found that the concentration of caffeine in the mother's plasma was usually higher (0.4-5.6 mg/liter) than the concentration in amniotic fluid (0.2-1.6 mg/liter).
Because the fetus swallows 500 ml of amniotic fluid daily during the last trimester, the ingestion of caffeine by the fetus may be several milligrams per day, depending on the concentration of caffeine in the mother's plasma.
When the transfer of drugs from the maternal circulation to breast milk was investigated, it was found that all of the drugs ingested by the mother were transferred to breast milk. Tolbutamide Secobarbital kilogram body weight basis, the neonate frequently receives an adult dose. The half-lives of drugs in breast milk and plasma were compared. The samples (2-5 ml) were obtained from mothers who were no longer nursing their infants. Figure 5 shows a comparison of the analyses of plasma and breast milk after ingestion of a single 100-mg dose of diphenylhydantoin.
Although the concentration of the drug was lower in breast milk than plasma, the half-life of diphenylhydantoin was longer (7 h, 20 mm) in breast milk than in plasma (5 h, 20 mm). The respective half-lives calculated by the use of regression analysis were 7 h, 36 mm, and 5 h, 
GC-MS-COM
methods are particularly useful in pharmacokinetic studies because of the specificity of detection.
The original drug can be distinguished readily from its metabolites, and as a result the measurements represent the concentration of the parent drug, not the combined concentrations of one or more compounds having the same spectrophotometric
properties. But the concentration of the individual metabolites can also be measured, as exemplified in Figure 6 . After ingestion of mephobarbital, the plasma concentrations of mephobarbital and its metabolite, phenobarbital, were followed in two individuals and half-lives of mephobarbital determined.
In the subject for whom the half-life was shorter (34 h) the concentration of phenobarbital in plasma became constant between 48 and 72 h. In the subject for whom the half-life was longer, it took more than 96 h for the phenobarbital concentration to become constant. The dose ingested by the two subjects was not significantly different when calculated on a milligram per kilogram body weight basis. The concentrations of free and conjugated hydroxyphenobarbital are also being determined for these samples in an attempt to explain the plateauing of the phenobarbital values. All of these measurements can be made on 1-2 ml of plasma.
GC-MS-COM methods have also been used in toxicological studies. A very effective GC-MS-COM system has been developed by Costello et al. (9) for rapidly identifying drugs in urine, blood, and gastric juice obtained from overdose patients. One or more toxic agents were identified in 75% of the 600 cases studied.
In our studies, adverse reactions to drugs-including withdrawal symptoms-have been investigated in infants.
Neonates The half-lives were determined as descrIbed in FIgure 5. When regression analysis was used, the half-lives were 46.5and 37.8 h urine sample was obtained from the mother at delivery and timed urine samples were collected from the infant for 22 days. The infant was not breast fed. When GC methods were used, it was possible to follow the excretion of phenobarbital for only eight days and mephobarbital was only detected on day 1. When selective ion detection was used, mephobarbital was identified and quantified in urines collected through day 8 and phenobarbital was identified and quantified in urines collected through day 22 (Table 4 ). The excretion of phenobarbital could have been followed even longer if samples had been available, because the limit of of detection of the analytical system had not been reached.
The time of each urine collection was recorded, so it was possible to calculate the half-life of mephobarbital and phenobarbital from the rate of urinary ex-cretion of the two drugs. The half-life of mephobarbital was 30 h (days 1-5) and the half-life of phenobarbital was 48 h (days 8-14) during the log-linear phase. The excretion rate for phenobarbital decreased between days 14 and 22, resulting in an increased half-life, indicating that trace amounts of phenobarbital persisted in neonatal tissues for several weeks after the last urine sample was collected on day 22. In a study involving administration of phenobarbital to a premature infant, it was possible to identify and quantify the drug in neonatal urine 60 days after ingestion of the last dose.
From the examples that have been described, it is evident that these analytical systems can be used effectively in many areas of clinical research. In addition to specificity and sensitivity of detection, GC-MS-COM systems can be used to monitor any drug or compound of biological interest without changing the analytical system as long as (a) the compound is or can be made volatile and (b) the molecular weight of the compound lies within the mass range of the mass spectrometer.
The chemical-ionization mode is preferred to the electron-impact mode because very little fragmentation is observed in CI spectra. As a result, the probability that fragment ions from other compounds in the biological sample will contribute to the intensity of the ion(s) being monitored is markedly reduced. The GC-MS-COM system we used is operated only in the CI mode without a separator and at 1 Torr. This type of analytical system is easier to operate and maintain than are magnetic sector instruments operated in the electron-impact mode. In our experience the precision of these methods is 2-6%; under the most favorable circumstances (for example, using [2,4,5-'3C]phenobarbital in the measurement of phenobarbital in biological samples) the precision is 1-2%. The accuracy is of the same magnitude but varies with specific applications.
Although it would be difficult to introduce GC-MS-COM systems into most hospital clinical chemistry laboratories in their present configuration, they are being used in a few of these laboratories currently monitoring concentrations of drugs in the blood. Their use would undoubtedly increase if their operation were automated.
